Adial Pharmaceuticals (NASDAQ:ADIL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Adial Pharmaceuticals (ADIL) operate in?

Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Adial Pharmaceuticals Stock (NASDAQ: ADIL) stock price, news, charts, stock research, profile.

Open	$0.76
Close	$0.74
Volume / Avg.	83.76K / 179.72K
Day Range	$0.72 - $0.78
52 Wk Range	0.72 - 4.17
Market Cap	$4.80M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	0.95%
Days to Cover	1

Recent News

EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

Adial Pharmaceuticals received a U.S. patent for genetic marker-based treatment methods and completed a pharmacokinetics study supporting its Phase 3 trial.

Vandana Singh

EXCLUSIVE: Adial Pharmaceuticals Reveals Positive Pharmacokinetics Study Results Of AD04 For Alcohol Use Disorder

Adial Pharmaceuticals announced completion of PK study for AD04, confirming predictable bioavailability, dose proportionality, and no food effect.

Akanksha Bakshi

EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations

Adial Pharmaceuticals expands its IP with a U.S. patent for targeted AUD treatment using AD04, supporting its personalized medicine strategy.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.76
Close	$0.74
Volume / Avg.	83.76K / 179.72K
Day Range	$0.72 - $0.78
52 Wk Range	0.72 - 4.17
Market Cap	$4.80M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	0.95%
Days to Cover	1

About Adial Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Adial Pharmaceuticals (ADIL) stock?

You can purchase shares of Adial Pharmaceuticals (NASDAQ:ADIL) through any online brokerage.

View our list of the best stock brokerages

Who are Adial Pharmaceuticals (ADIL) competitors?

Other companies in Adial Pharmaceuticals’s space includes: 60 Degrees (NASDAQ:SXTP), Jaguar Health (NASDAQ:JAGX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Redhill Biopharma (NASDAQ:RDHL) and CNS Pharma (NASDAQ:CNSP).

What is the forecast, or price target, for Adial Pharmaceuticals (ADIL) stock?

Adial Pharmaceuticals has a consensus price target of $7.00.

What is the current price for Adial Pharmaceuticals (ADIL)?

The stock price for Adial Pharmaceuticals (NASDAQ: ADIL) is $0.741001 last updated February 14, 2025 at 7:06 PM EST.

Does Adial Pharmaceuticals (ADIL) pay a dividend?

There are no upcoming dividends for Adial Pharmaceuticals.

When is Adial Pharmaceuticals (NASDAQ:ADIL) reporting earnings?

Adial Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Adial Pharmaceuticals (ADIL) going to split?

There is no upcoming split for Adial Pharmaceuticals.

What sector and industry does Adial Pharmaceuticals (ADIL) operate in?

Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Adial Pharmaceuticals

Adial Pharmaceuticals (ADIL) Forecast